DANIEL LYNCH Insider Trading

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for DANIEL LYNCH.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of DANIEL LYNCH. DANIEL LYNCH is an Acting Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and an Chief Executive Officer in IMCLONE SYSTEMS INC ($IMCLE) and a in bluebird bio, Inc. ($BLUE) and a Director in bluebird bio, Inc. ($BLUE) and a Director in BIND Therapeutics, Inc ($BIND) and a Director in Eleven Biotherapeutics, Inc. ($EBIO) and a Director in Blueprint Medicines Corp ($BPMC) and a Director in Translate Bio, Inc. ($TBIO) and a Director in Surface Oncology, Inc. ($SURF) and a Director in SpringWorks Therapeutics, Inc. ($SWTX).

Companies in which DANIEL LYNCH is an Insider

bluebird bio, Inc.

Trading Symbol: BLUE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH:
Holdings: 5,859 shares
Current Value: $431,808
Latest Transaction: Jun 22 2020
$BLUE Market Capitalization: $2.75B
$BLUE Previous Close: $73.70

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 22x
Sell: 19x
Shares Bought: 31,959
Shares Sold: 24,000
Share Difference: +7,959
Value Difference: +$2,282,310

Blueprint Medicines Corp

Trading Symbol: BPMC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL LYNCH: Director
Holdings: 127,904 shares
Current Value: $4,584,079
Latest Transaction: Jun 26 2020
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84

Last 4 weeks trend: STRONG SELL
Last 3 months trend: STRONG SELL View transactions

Last 3 Months Overview:
Buy: 2x
Sell: 19x
Shares Bought: 3,562
Shares Sold: 158,700
Share Difference: -155,138
Value Difference: +$5,841,151

DNIB UNWIND, INC.

Trading Symbol: BIND
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL LYNCH: Director
Holdings: 20,000 shares
Latest Transaction: Aug 30 2016

Last 4 weeks trend: BUY
Last 3 months trend: BUY View transactions

Last 3 Months Overview:
Buy: 1x
Sell: 0x
Shares Bought: 20,000
Shares Sold: 0
Share Difference: +20,000
Value Difference: -$8,800

IMCLONE SYSTEMS INC

Trading Symbol: IMCLE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Acting Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Dec 22 2004

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Sesen Bio, Inc.

Trading Symbol: SESN
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 21 2019
$SESN Market Capitalization: $34.48M
$SESN Previous Close: $2.34

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

SpringWorks Therapeutics, Inc.

Trading Symbol: SWTX
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Latest Transaction: May 22 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Surface Oncology, Inc.

Trading Symbol: SURF
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Latest Transaction: Jun 12 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Translate Bio, Inc.

Trading Symbol: TBIO
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DANIEL LYNCH: Director
Holdings: 0 shares
Latest Transaction: Jun 17 2020

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions

Latest Insider Trading Transactions of DANIEL LYNCH

Sentiment: All, BLUE, BPMC, BIND, IMCLE, SESN, SWTX, SURF, TBIO

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jun 26 2020BPMCBlueprint Medicine ...LYNCH DANIELDirectorOption ExerciseA76.244,500343,0804,500
Jun 26 2020BPMCBlueprint Medicine ...LYNCH DANIELDirectorGrantA0.002,2500127,904125.7 K to 127.9 K (+1.79 %)
Jun 23 2020BPMCBlueprint Medicine ...LYNCH DANIELDirectorOption ExerciseM0.001,31200
Jun 23 2020BPMCBlueprint Medicine ...LYNCH DANIELDirectorBuyM0.001,3120125,654124.3 K to 125.7 K (+1.06 %)
Jun 22 2020BLUEbluebird bio, Inc.LYNCH DANIELOption ExerciseA64.094,200269,1784,200
Jun 22 2020BLUEbluebird bio, Inc.LYNCH DANIELGrantA0.002,10007,9595.9 K to 8 K (+35.84 %)
Jun 22 2020BLUEbluebird bio, Inc.LYNCH DANIELGrantA0.0025905,8595.6 K to 5.9 K (+4.63 %)

View all DANIEL LYNCH insider transactions.